Skip to main content
Clinical Trials/NCT05184556
NCT05184556
Active, Not Recruiting
N/A

Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders

University of Pittsburgh4 sites in 1 country77 target enrollmentAugust 1, 2022

Overview

Phase
N/A
Intervention
Integrative family therapy
Conditions
Anorexia Nervosa
Sponsor
University of Pittsburgh
Enrollment
77
Locations
4
Primary Endpoint
Body mass index percentile
Status
Active, Not Recruiting
Last Updated
18 days ago

Overview

Brief Summary

This randomized, controlled effectiveness trial will assess outcomes, implementation, and mechanisms of two psychological treatments for adolescent anorexia nervosa (AN) delivered in the home setting, in the context of community-based mental health. Adolescents with AN-spectrum disorders (n=50) and their caregivers will be randomly assigned to either family-based treatment or integrated family therapy delivered in the home. Caregivers and adolescents will provide data on weight, eating, and putative treatment mechanisms, including caregiver self-efficacy, adolescent distress, and generalizability of treatment skills. Treatment feasibility, acceptability, and appropriateness will be measured among providers and participating families. The proposed study has clear potential to advance scientific and clinical understanding of the real-world effectiveness of psychological treatments for AN, including whether adapting them for the home setting may improve accessibility and effects on treatment outcome

Detailed Description

Participants (adolescents with AN-spectrum and their parents) are asked to complete study assessments at 5 time points: baseline and 6-, 12-, 24-, and 32-weeks after starting treatment. The 32-week time point was added approximately a year into the study, at the suggestion of the Program Officer. The research team noted that some families are still in treatment at the time of the 24-week assessment, so these data do not capture post-treatment thoughts and behaviors. To better assess post-treatment outcomes, a 32-week assessment was added to protocol.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
April 30, 2026
Last Updated
18 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Andrea Goldschmidt

Associate Professor

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Meets criteria for AN or atypical AN according to DSM-5 diagnostic criteria.
  • Currently living at home with caregivers who are willing to engage in family treatment.
  • Medically stable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine (e.g., ≥75% of expected body weight, heartrate ≥50 beats per minute) and receiving medical monitoring from a clinician throughout treatment.
  • If on psychotropic medication, meets all eligibility criteria while on stable dose of psychotropic medication for a co-morbid condition.
  • Available for follow-up.

Exclusion Criteria

  • Associated physical illness that necessitates hospitalization.
  • Psychotic illness/other mental illness requiring hospitalization.
  • Current dependence on drugs or alcohol.
  • Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight.
  • Concurrent involvement in other psychological treatment for an eating disorder.
  • Developmental delay that would preclude participation in the intervention.

Arms & Interventions

Integrative family therapy

Families will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care

Intervention: Integrative family therapy

Family-based treatment

Families will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care

Intervention: Family-based treatment (FBT)

Outcomes

Primary Outcomes

Body mass index percentile

Time Frame: Up to 32-weeks post randomization

Adolescents will have their height and weight measured to calculate BMI percentile using CDC growth charts and accompanying procedures.

Eating Disorder Examination

Time Frame: Up to 32-weeks post randomization

The Eating Disorder Examination will be used to diagnose anorexia nervosa, and assess eating disorder behaviors, attitudes, and cognitions. Items are scored from 0-7 and averaged to create subscales reflecting restraint, eating concerns, shape concerns, weight concerns, and global eating-related psychopathology. Higher scores indicate more severe eating disorder symptoms.

Secondary Outcomes

  • Acceptability, Appropriateness, and Feasibility of Intervention Measure(Up to 3 years)
  • Therapeutic Technique Scale(Up to 3 years)
  • Engagement(Up to 3 years)
  • Enrollment(Up to 3 years)
  • Abbreviated Acceptability Rating Profile(Up to 32-weeks post randomization)
  • Therapy Suitability and Patient Expectancy(Up to 32-weeks post randomization)
  • Acceptability, Appropriateness, and Feasibility of Intervention Measure(Up to 3 years)
  • Multi-theoretical List of Therapeutic Interventions(Up to 32-weeks post randomization)
  • Therapeutic Technique Scale(Up to 3 years)
  • Engagement(Up to 3 years)
  • Client Satisfaction Questionnaire(Up to 32-weeks post randomization)
  • Enrollment(Up to 3 years)
  • Attendance(Up to 32-weeks post randomization)
  • Completion(Up to 32-weeks post randomization)

Study Sites (4)

Loading locations...

Similar Trials